Single Use Bioreactors Market Development And Business Intelligence

Summary

• Market Growth Factors & Global Market Size.
• Leading Players & Top Segments.
• Geographic Overview.

Market growth influenced due to following factors-

• The Increasing adoption of SUBs among small companies and startups.
• Reduced automation complexity.
• Technological advancements in SUBs.
• Increasing Biopharmaceutical R&D are factors driving the growth of this market.

Global market size-

According to the new market research report Single use Bioreactors Market is projected to reach USD 3.9 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 18.0% 

Leading Players-

The prominent players operating in the Single-use Bioreactors Market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany).

Top Market Segments-

Based on product, the market is categorized into single-use bioreactor systems, single-use media bags, single-use filtration assemblies, and other products such as single-use vessels, tubing, connectors, control systems, and probes/sensors, among others. The single-use bioreactor systems segment dominated the market in 2019. SUB systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharma applications.

Based on type, the market is categorized into wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors such as hybrid bioreactors and SUBs with vertically perforated discs. The stirred-tank SUBs segment dominated the market in 2019. The stirred-tank SUBs are highly preferred in the cultivation of aerobic microbial cultures as it promote greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.

For Details, Download PDF Brochure Here

Geographic Overview -

North America accounted for the largest share of the market, followed by Europe in 2019. The large share of the North American regional segment can be attributed to the presence of a well-established biopharmaceutical industry and major players operating in the market.